FGF21 Alleviates Hepatic Endoplasmic Reticulum Stress under Physiological Conditions

• Published in: Journal of Nutritional Science and Vitaminology 2018, Vol.64(3), pp.200-208
• Main Authors: MARUYAMA, Ryuto, SHIMIZU, Makoto, HASHIDUME, Tsutomu, INOUE, Jun, ITOH, Nobuyuki, SATO, Ryuichiro
• Format: Article
• Language: English
• Subjects: ATF4; ER stress; FGF21; β-conglycinin
• ISSN: 0301-4800; 1881-7742
• DOI: 10.3177/jnsv.64.200

Fibroblast growth factor 21 (FGF21), mainly synthesized and secreted from the liver, is an endocrine FGF that regulates glucose and fatty acid metabolism to maintain whole body energy homeostasis. Gene expression of FGF21 was previously reported to be induced by endoplasmic reticulum (ER) stress through activating transcription factor 4 (ATF4). It has been reported that drug-induced ER stress is reduced by overexpression of FGF21. However, the function of endogenous FGF21 under physiological conditions such as the postprandial state remains unknown. Here, we examined the effects of both endogenous and exogenous FGF21 on postprandial hepatic ER stress. In mice, postprandial and tunicamycin-induced ER stress was significantly reduced by overexpression of FGF21 using a recombinant adenovirus. FGF21-deficient mice exhibited a more considerable increase in drug-induced ER stress target gene expression than wild-type mice. Following refeeding after fasting, FGF21 deficiency caused severe ER stress in the liver. The postprandial ER stress response was significantly reduced when hepatic FGF21 gene expression was increased by feeding a diet containing the soy protein β-conglycinin which activates ATF4. Together, these results demonstrate that FGF21 reduces the increased expression of a subset of genes in the liver in response to ER stress and may correct metabolic disorders caused by ER stress.